NCT01491113View on ClinicalTrials.gov

Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Healthy SubjectsRenal Impairments

Interventions

DRUG

Levetiracetam 250 mg

Tablet containing Levetiracetam 250 mg

DRUG

Levetiracetam 500 mg

Tablet containing Levetiracetam 500 mg

Trial Locations (2)

Unknown

1, Fukuoka

2, Ibaraki

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Parexel

INDUSTRY

lead

UCB Pharma

INDUSTRY